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Objective: To identify and compare implementation bottlenecks for effective coverage of screening for syphilis,
HIV, and anemia in antenatal care in rural Tanzania and Uganda; and explore the underlying determinants and
perceived solutions to overcome these bottlenecks. Methods: In this multiple case study, we analyzed data
collected as part of the Expanded Quality Management Using Information Power (EQUIP) project between
November 2011 and April 2014. Indicators from household interviews (n = 4415 mothers) and health facility
surveys (n = 122) were linked to estimate coverage in stages of implementation between which bottlenecks
can be identiﬁed. Key informant interviews (n = 15) were conducted to explore underlying determinants and
analyzed using a framework approach. Results: Large differences in implementation were found within and be-
tween countries. Availability and effective coverage was signiﬁcantly lower for all tests in Uganda compared
with Tanzania. Syphilis screening had the lowest availability and effective coverage in both countries. The
main implementation bottleneck was poor availability of tests and equipment. Key informant interviews
validated these ﬁndings and perceived solutions included the need for improved procurement at the central
level. Conclusion: Our ﬁndings reinforce essential screening as a missed opportunity, caused by a lack of integra-
tion of funding and support for comprehensive antenatal care programs.
© 2015World Health Organization; licensee Elsevier. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).
1. Background
Screening for syphilis, HIV, and anemia is an essential element of
antenatal care (ANC) and its importance remains uncontested [1,2].
Almost two-thirds of adverse outcomes in newborns could be prevented
through effective screening followed by treatment and/or prophylaxis for
mothers infected with syphilis and/or HIV, respectively [3,4]. Anemia is a
frequent indirect cause ofmaternalmortality [5]. Despite the emphasis on
screening in the focused ANC strategy launched by WHO in the early
2000s, coverage of screening for syphilis, HIV, and anemia remains low
in many settings [6].
In Tanzania and Uganda, both countries with a high maternal and
newborn mortality, screening for adverse conditions in pregnancy has
long been included in national policies [7]. Before the arrival of rapid
point-of-care tests for syphilis in 2005, storage and the time needed to
perform the rapid plasma regain test constituted major barriers to
implementation [8]. Since 2010, rapid point-of-care tests for syphilis
have been available in both Tanzania and Uganda [9]. Testing for HIV
during pregnancy became an integral part of ANC for prevention of
mother-to-child transmission (PMTCT) in the early 2000s and is
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routinely available in most facilities offering ANC. In contrast, screening
for anemia is largely restricted to facilities with laboratory services [10].
In both countries, maternal health policies aim to provide user-
friendly integrated services, whilst achieving results and providing
value for money [11]. Comparing the coverage of screening tests repre-
sents an opportunity to monitor the implementation of such policies
[12]. However, studies on integrated care have primarily examined sin-
gle aspects such as the acceptability of offering several tests during the
same visit [13] or of dual testing [14]. Such studies evaluate the
feasibility of integration at the point of service delivery but not the
effectiveness of integrated services within a health system [15].
Herein, the implementation bottlenecks for effective coverage of
syphilis, HIV, and anemia screening in rural Tanzania and Uganda are
identiﬁed and compared utilizing a novel approach linking data from
households and health facilities to estimate population coverage in stages
of implementation and key informant interviews to explore underlying
determinants and potential solutions to the identiﬁed bottlenecks.
2. Methods
2.1. Study design and setting
This multiple case study [16] was nested within the Expanded
Quality management Using Information Power (EQUIP) project, a
district-wide collaborative quality improvement intervention for
maternal and newborn care implemented between 2011 and 2014 in
rural south-eastern Tanzania (Tandahimba district) and eastern
Uganda (Mayuge district) [17,18]. One of the many areas of improve-
ment focused on increasing consistent syphilis screening during ANC.
The study regions have high maternal and newborn mortality, with
6% and 8% of adult women being HIV positive in Tanzania and Uganda,
respectively [19,20]. Population-based syphilis prevalence in adult
women is 2% in Uganda, whereas sentinel surveys in pregnant women
show a syphilis prevalence of 4% in Tanzania [19,20].
2.2. Data collection
As part of EQUIP, surveys of households and health facilities were
implemented to generate data for quality improvement and project
evaluation [18]. These surveys were also conducted in adjacent non-
intervention districts (Newala, Tanzania; and Namayingo, Uganda).
The household survey was a continuous cluster sample survey
implemented between November 2011 and April 2014 where, each
month, 10 household clusters were selected with a probability propor-
tional to the population size of each district. Within each cluster, 30
households were sampled using simple random sampling. Interviews
were held with all resident women of reproductive age (13−49 years;
n = 27 957), applying a special module for those with a recent live
birth; mean age was 30 years (interquartile range 30−39) and 63%
were married. Questions included utilization of health services during
pregnancy and delivery, type of care received, and perceptions of quality.
During analysis, participants were limited to women with a live birth in
the 12 months prior to the survey (n = 4415).
The health facility survey was a census of all 122 health facilities,
repeated six times at four-month intervals during the study period. A
checklist was used to assess facility readiness in terms of availability
of drugs and equipment and interviews were conducted with the in-
charge regarding the provision of routine care [18].
Fifteen purposively sampled key informants were interviewed in
February 2014 in Tandahimba, Tanzania, and in November 2014 in
Mayuge, Uganda. Three key informants at the district level were
interviewed in each country. At the health facility level, six interviews
Fig. 1. Implementation pathway for essential screening tests during antenatal care (ANC). Adapted from Baker et al. [22]. Coveragemeasures with their deﬁnitions are outlined. Arrows in
the deﬁnition column represent the conditionality of the stages in the pathway. Attritions in coverage, the bottlenecks causing these, and their possible determinants are illustrated.
S44 U. Baker et al. / International Journal of Gynecology and Obstetrics 130 (2015) S43–S50
were conducted in Tanzania and three in Uganda. In Tanzania, these
interviews were part of a larger qualitative study exploring bottlenecks
in the district health service and healthworkers were sampled to repre-
sent different facility levels (hospital, health center, or dispensary). In
Uganda, the interviews were conducted for the purpose of this study
and were sampled to represent two health facility levels (health center
II and III). All interviews were recorded. Transcription was verbatim in
all but three cases where summary notes were made and illustrative
quotes captured verbatim.
2.3. Bottleneck analysis
An adapted Tanahashi model [21], the implementation pathway,
was used as suggested by Baker et al. [22]. This model allows for
estimating coverage in conditional stages of implementation between
which bottlenecks can be identiﬁed (Fig. 1). The stages of this
pathway include (1) accessibility coverage; (2) availability coverage;
and (3) effective coverage.
The target population was deﬁned as all pregnant women. Acces-
sibility to screening was estimated using ANC attendance (at least
once for syphilis and HIV and at least twice for anemia). Availability
coverage was conditional onmothers having attended ANC at a clinic
where the tests were available. This was estimated by linking data on
ANC attendance from the household survey with data on test avail-
ability from the household census. This analysis was stratiﬁed so
that the proportion of mothers attending a dispensary, health center,
or hospital for ANC was multiplied by the proportion of dispensaries,
health centers, or hospitals with the screening test in stock. Stratiﬁed
results were summarized to form an overall availability coverage for
each screening test.
Effective coveragewas conditional onmothers having attended ANC
in a health facility where the screening tests were available and who
reported having had the test. In the case of anemia, no speciﬁc indicator
was available and mothers’ reports of having had blood drawn for any
test were used as a proxy indicator (Fig. 1).
Bottlenecks along the implementation pathway were measured as
absolute attrition in coverage from one stage to the next and were
given the overall labels: access (attrition from target population to acces-
sibility coverage); health facility readiness (attrition from accessibility to
availability coverage); and clinical practice (attrition from availability to
effective coverage) (Fig. 1). STATA 12 (StataCorp, College Station, TX,
USA) was used for the analysis. Stratiﬁcation and multiplicative analysis
to construct the coverage measures was performed in Excel (Microsoft;
Redmond, WA, USA).
2.4. Qualitative framework analysis
Key informant interviews were analyzed using framework analysis
[23]. The analysis stages included: (1) familiarizationwithdata; (2)devel-
oping pre-determined key themes to be explored; (3) indexing interview
data under relevant themes while noting down any emergent
new themes in the data; and (4) summarizing and reducing data in an
Excel spreadsheet.
2.5. Ethical considerations
The study was granted ethical clearance from the National Institute
of Medical Research in Tanzania and fromMakerere University, College
of Health Sciences, School of Public Health, Higher Degrees Research
and Ethics Committee in Uganda through the EQUIP project.
3. Results
3.1. Overview
Data from 4415 women with a live birth in the 12 months prior to
the household survey and from six repeated censuses of 122 health
facilities was analyzed (Table 1). Availability of screening tests at each
health facility census is displayed in Fig. 2.
Table 1
EQUIP survey sample sizes.
Tanzania
(n)
Uganda
(n)
Total
(n)
Households interviewed 14 215 13 125 27 340
Women of reproductive age (13–49 years) interviewed 13 239 14 718 27 957
Women with a live birth in the past 12 months 1422 2933 4415
Number of health facilities surveyed (6 time points) 63 59 122
Fig. 2. Proportion of health facilities with availability of screening tests at different time points in Tanzania (a) and Uganda (b).
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3.2. Bottleneck analyses
In Tanzania, effective coverage of screening tests was estimated at
15% (213/1422) for syphilis, 65% (924/1422) for HIV, and 51% (725/
1422) for anemia (Fig. 3a). For all three tests, accessibility coverage
was universal or near-universal. The largest bottleneck was poor health
facility readiness, i.e. test shortages, causing an attrition of 57% (811/
1422) for syphilis screening and 42% (597/1422) for anemia screening.
For HIV screening, test shortages only caused an attrition in coverage of
17%. Clinical practice represented a second large bottleneck, causing an
attrition of 28% for syphilis screening and of 18% for HIV testing. For ane-
mia, there was minimal attrition from availability to effective coverage.
Fig. 3. Implementation pathway for screening of syphilis, HIV, and anemia (Hb) in Tanzania (a) and Uganda (b). Coverage for each stage of implementation is indicated at the top of the
bars. Main bottlenecks causing attrition in coverage are indicated in text boxes with attrition in percent indicated below in between bars.
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Table 2
Main themes and subthemes from qualitative framework analysis.
Themes Subthemes Tanzania Uganda Tanzania Uganda Tanzania Uganda
Syphilis HIV Hemoglobin
Availability Low Low High Moderate Low Low
Determinants of availability and
effective coverage
Supply chain • Stock-out in MSD
• No buffer stock kept at
district level
• Expired tests
• Lack of coordination in
MSD
• Delay in ordering from
health facilities
• Irregular supply from NMS
• Ordering from health facili-
ties via district not
satisfactory
• Procurement of HIV
tests priority in MSD
• Regular supply of test kits
from NMS
• Previous buffer of test kits
stopped
• Ordering from health facili-
ties via district not
satisfactory
• Stock-out in MSD • Irregular supply from NMS
• Ordering from health facili-
ties via district not
satisfactory
Financing and
implementation
support
• No external support
• Budget tied to MSD
• No external support
• Few health facilities with
laboratory
• External support
• PMTCT in all health
facilities
• External support
• Few health facilities with
laboratory
• Limited external
support
• Budget tied to MSD
• Few health facilities
with Hemocue
• No external support
• Few facilities with
laboratory
ANC clinical practice • Heavy work load
• Lack of health worker
knowledge
• Long waiting
• Mothers arrive late
• Mothers refuse testing
• Heavy work load
• Health workers motivated to
test
• Long waiting
• Mothers arrive late
• Mothers refuse testing
• Heavy work load
• Lack of health worker
knowledge
• Long waiting
• Mothers arrive late
• Mothers refuse testing
Importance of testing/consequences
of low availability
• Mothers not tested
• Clinical assessment
• Counselling undermined
• Mothers not tested • Mothers not tested • Mothers not tested • Mothers not tested
Solutions to overcome low availability
and effective coverage
Supply chain • Improved feed-back on
stock-outs from MSD
• Increase size of test kits
• Order directly from health
facilities
• Improve planning and
communication
• Increase size of test kits
• Order directly from health
facilities
• Improve planning and
communication
• Increase size of test kits
• Order directly from health
facilities
• Improve planning and
communication
Financing and
implementation
support
• External support
• Integrate screening
programs
• Use alternative funds to
procure tests outside of
MSD
• External support
• Roll-out to more health center
levels
• Increase number of health
workers for ANC
• External support
• Roll-out to more health
center levels
• Increase number of health
workers for ANC
• External support
• Equip all health fa-
cilities with
Hemocue
• External support
• Roll-out to more health
center levels
• Increase number of health
workers for ANC
ANC clinical practice • Request tests from
nearby facilities
• Delay testing
• Refer to other health
facility
• Increase health workers’
knowledge
• Increase mothers’ knowledge
of reason for testing
• Increase health workers’
knowledge
• Increase mothers’ knowl-
edge of reason for testing
• Refer to other
health facilities
• Increase health workers’
knowledge
• Increase mothers’ knowl-
edge of reason for testing
Abbreviations: ANC, antenatal care; MSD, Medical Stores Department; NMS, National Medical Stores; PMTCT, prevention of mother-to-child transmission.
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In Uganda, effective coverage of the screening tests was estimated at
3% (88/2933) for syphilis, 37% (1085/2933) for HIV, and 19% (557) for
anemia (Fig. 3b). Accessibility coverage was 95% (2786/2933) for
syphilis andHIV and 92% (2698/2933) for anemia screening. The largest
bottleneck was health facility readiness, causing a large attrition for
both syphilis and anemia of 79% and 69%, respectively, as well as a sub-
stantial attrition (39%) from accessibility to availability coverage of HIV
screening. Clinical practice causedminor attrition fromavailability to ef-
fective coverage of syphilis andHIV screening (13% and 19%, respective-
ly) and even less for anemia screening (4%).
3.3. Overview qualitative framework analysis
The overarching themes, sub-themes, and categories explored in the
framework analysis are outlined in Table 2, with the main ﬁndings
elaborated below.
3.3.1. Availability of tests
In Tanzania, informants conﬁrmed the low availability of tests and
equipment to screen for syphilis and anemia while the availability of
HIV tests was not perceived as a problem. In Uganda, availability was
expressed as a problem for all three screening tests, although less so
for HIV.
“We have run out of syphilis tests but we have those for HIV.” (Nurse,
Dispensary, Tanzania)
“HIV testwould be okay because all themothers who come are all tested
and testing tubes are abundantly available.” (Member of District
Health Management Team, Uganda)
3.3.2. Determinants of availability and effective coverage
In Tanzania, the main reason for low availability of syphilis tests and
hemoglobin test cuvettes was perceived to be stockouts in the Medical
Stores Department (MSD). No external partner provided the district
with support for syphilis screening and, as the district’s budget is tied
to the MSD, procurement from alternative sources during stockouts
is difﬁcult.
“Money can be there but if the items are not there [atMSD]we don’t get
[them] but we can’t get our money back.” (Member of Council Health
Management Team (CHMT), Tanzania)
Procurement of HIV tests was perceived to be given priority by the
MSD over other tests and external partners provided test kits in parallel
with the MSD. Anemia screening had received some support from the
Elizabeth Glaser Pediatric AIDS Foundation through its PMTCT program.
In Uganda, health facilities submit their orders through the district
rather than directly to the National Medical Stores (NMS); this was
perceived to result in suboptimal procurement.
“We do monthly reporting but I don’t think they [the district manage-
ment] follow them […] in the end, they don’t supply us with the kits.”
(Health worker, Health center III, Uganda)
The implementation of either syphilis or anemia screening in
Uganda was not supported by external partners, while this was the
case for HIV. However, the Ministry of Health had recently stopped
the parallel procurement of HIV test kits by external partners in an effort
to improve coordination.
In Tanzania, no key informants discussed the role of clinical practice
in ANC as a determinant. In Uganda, the heavy workloadwas perceived
to be a factor in the inconsistent performance of screening despite tests
being available. Mothers were perceived to have poor knowledge of
reasons for syphilis and anemia screening and to avoid the laboratory
if waiting times were long.
“When you delay them [mothers] here [at ANC], they end up not doing
some tests.” (Health worker, Health center III, Uganda)
In Uganda, there was also a perception of insufﬁcient knowledge
among health workers on the importance of screening for syphilis
and anemia. For HIV screening, on the other hand, the motivation
to test was perceived to be higher due to the knowledge of PMTCT
and a personal need for infection control measures at the time of
delivery.
3.3.3. Consequences of low test availability
In both countries, the obvious consequence of low test availability
was that mothers were not being screened. In Tanzania, health workers
expressed reverting to clinical examination to assess signs of syphilis
and to refer suspicious cases for testing. The shortage of tests was
also perceived to undermine counselling of mothers on the importance
of testing.
“Even if you tell the mother [about syphilis], it doesn’t help because
the tool for testing syphilis is not available.” (Nurse, Health
center, Tanzania)
3.3.4. Solutions to overcome low test availability
In Tanzania, the district suggested improved reporting from theMSD
during syphilis tests stockouts. Support from external partners for
syphilis screening and improved integration of support for ANC was
also expressed as a key solution.
“If these [external partners] could support us […] and not focus only on
HIV, HIV [testing] is not a problem.” (Member of CHMT, Tanzania)
Another strategy occasionally employed by the district in Tanzania
was to use cost sharing funds, i.e. patient fees, to procure syphilis tests
from private pharmacies when the MSD was out of stock. Mothers
were sometimes referred to test in other facilities or tests were request-
ed form nearby districts.
“We normally request either from Newala or Masasi [nearby
districts], we normally share whatever we have.” (Nurse, District
hospital, Tanzania)
In Uganda, the perceived key solutions to increase screening cover-
age included further external support, extending testing to more health
center levels, and recruiting additional health workers for ANC. The
possibility of health facilities placing orders directly to the NMS was
also perceived as important.
“If they can allow us [health facilities] to make requisitions [to the
NMS] by ourselves, it will help us.” (Health worker, Health center
III, Uganda)
4. Discussion
Effective coverage of essential screening for pregnant mothers
remains low in Tanzania and Uganda, with the highest effective cover-
age achieved for HIV in Tanzania (65%) and the lowest for syphilis in
Uganda (3%). The main bottleneck identiﬁed in both countries was the
shortage of tests and equipment. Overall, the availability of tests was
higher in Tanzania than in Uganda. The availability of HIV tests
was signiﬁcantly higher than that for syphilis and anemia in both
settings. Perceptions of the underlying determinants included lack of
integration of support for different aspects of ANC and central level
procurement problems.
The estimates of test availability are close to those from recent
national surveys in both countries [24,25]. For syphilis and HIV
screening, the results are also similar to the WHO estimates of 44%
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and 15% of pregnant women being tested for syphilis and 86% and
63% being tested for HIV in Tanzania and Uganda, respectively [26].
To our knowledge, international estimates for anemia screening are
not available.
Key informants in both countries expressed difﬁculties in ensuring a
regular supply of syphilis testing kits, pointing to procurement prob-
lems at the central level. This was also the experience from the EQUIP
study, where quality improvement teams in health facilities did not
identify any solutions to overcoming the low availability of syphilis
tests. This was different for other improvement areas where, for exam-
ple, the availability of oxytocin was ensured through consistent order-
ing routines. In both Tanzania and Uganda, screening tests for syphilis
and HIV are partly funded by external partners, while logistics is inte-
grated into the national procurement and supply system. In Tanzania,
external partners occasionally procure test kits from outside the MSD,
but this is mainly limited to HIV tests. In Uganda, a similar system has
recently been reformed with the aim to improve coordination. While
donor-driven procurement is not desirable, district stakeholders and
health providers see it as a potential solution.
The large differences in availability between the screening tests
reﬂect the strength of international support. PMTCT is high on the
agenda and ﬁnancially supported through the Global Fund. The
Eliminating Congenital Syphilis initiative, led by WHO, is less known
and supported [27], and apparently poorly funded, despite the strong
evidence base [3,28].
There is currently a strong consensus regarding the importance of
integrating health services and creating synergies to meet the health
needs of populations [29], as reﬂected in national policies. In Tanzania,
external partners support implementation of PMTCT within a frame-
work which states that “testing for HIV is an integral part of ANC and
should be accompanied with all other necessary tests such as syphilis,
hemoglobin and others” [30]. The present study, however, suggests
that such policies do not necessarily lead to the provision of integrated
services unless ﬁnancing and support are comprehensive rather
than selective.
4.1. Limitations
The present analysis did not include indicators of adequate treat-
ment as a result of screening. There was no access to such detailed
data; further, it would have complicated the comparative nature of
the analysis since treatments and endpoints differ. Deﬁnitions for the
stages of coverage along the implementation pathway were based on
simplifying assumptions. While early screening is important to ensure
the largest impact, the timing of the ﬁrst ANC visit was not included
[31]. The validity ofmothers’ reports is a generic problem for any survey
[32]; estimates of effective coverage could therefore have been
underestimated, although we believe that if screening and counselling
have been effective, mothers will remember. Indicators were not indi-
vidually linked between mothers and the particular health facilities
they attended; this could result in false low coverage estimates as
availability may be higher at the actual facility attended. Additionally,
stakeholder interviews at the national or regional levels could not be
included in this study although these could have provided further
explanation for testing material shortages within the national drug
distribution systems. Finally, while the study was conducted in typical
rural districts in Tanzania and Uganda [17], we believe that these results
are generalizable to both countries.
5. Conclusions and policy recommendations
The low effective coverage and large differences in availability of
tests for essential screening indicated herein reﬂect missed opportuni-
ties with severe health implications for mothers and newborns in
rural East Africa. A focus on developing mechanisms for joint ﬁnancing
and support for screening as part of care bundles for mothers and
newborns is required. Such a strategy may avoid the opportunity costs
of targeting a few priority conditions while leaving other essential
aspects of care underfunded.
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